CurrentRheuma
Get Weekly

Topic · page 27 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 1,041–1,080 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Ann Rheum Dis

    Haematopoietic stem cell-derived immune cells have reduced X chromosome inactivation skewing in systemic lupus erythematosus

    Case-control study

  2. Ann Rheum Dis

    Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Cohort study

  3. Arthritis Care Res (Hoboken)

    Training to Increase Minority Enrollment in Lupus Clinical Trials With Community Engagement: Enhancing Lupus Clinical Trial Recruitment Through Provider and Community Health Worker Engagement

    Research article

  4. Arthritis Res Ther

    Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus

    Mechanistic study

  5. Lupus

    Identification of common MicroRNAs expression signatures in antiphospholipid syndrome and thromboembolic disease: A scoping review

    Research article

  6. Clin Exp Rheumatol

    Disease activity and quality of life in patients with systemic lupus erythematosus: a validation study using the SLE-DAS

    Diagnostic or prognostic study

  7. Lupus

    Treatment adherence and quality of life in colombian patients with lupus nephritis

    Cross-sectional study

  8. Lupus Sci Med

    Real-world treatment patterns in patients with systemic lupus erythematosus: associations with comorbidities and damage

    Cohort study

  9. RMD Open

    Frailty is independently associated with subclinical cardiovascular disease in patients with systemic lupus erythematosus

    Cross-sectional study

  10. RMD Open

    Predicting the risk of cardiovascular and cerebrovascular event in systemic lupus erythematosus: a Chinese SLE treatment and research group study XXVI

    Diagnostic or prognostic study

  11. Lupus

    Needs for discharge planning and facilitators-barriers to implementing discharge plans for patients with SLE: A qualitative study

    Research article

  12. Lupus Sci Med

    VPS13C and STING expression in neuropsychiatric systemic lupus erythematosus: unveiling an unbreached territory

    Case-control study

  13. Arthritis Res Ther

    Use of belimumab in treating patients with systemic lupus erythematosus: a single-center, real-world retrospective study

    Cohort study

  14. RMD Open

    Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational study

    Cohort study

  15. Lupus Sci Med

    Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosus

    Cohort study

  16. RMD Open

    Safety, pharmacokinetics, biomarker response and efficacy of E6742: a dual antagonist of Toll-like receptors 7 and 8, in a first in patient, randomised, double-blind, phase I/II study in systemic lupus erythematosus

    Randomized controlled trial

  17. Rheumatology (Oxford)

    Development and validation of a nomogram for predicting the interstitial fibrosis and tubular atrophy in patients with lupus nephritis

    Diagnostic or prognostic study

  18. Rheumatology (Oxford)

    Efficacy, safety and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry

    Cohort study

  19. Lupus

    Impact of perception of illness on quality of life in juvenile systemic lupus erythematosus

    Cross-sectional study

  20. Lupus

    Genetic susceptibility and clinical features of CYP2D6 associated with systemic lupus erythematosus in a Chinese population

    Cohort study

  21. Lupus

    The experience and implications of pain in systemic lupus erythematosus: A qualitative interview study focusing on the patient’s perspective

    Research article

  22. Lupus

    Clinical outcomes of patients receiving long-term fondaparinux for thrombotic antiphospholipid syndrome

    Cohort study

  23. Lupus

    Cognitive impairment in a Colombian cohort of patients with systemic lupus erythematosus: A cross-sectional study

    Cross-sectional study

  24. Lupus

    Factors affecting discrepancies in disease activity evaluation between patients and physicians in systemic lupus erythematosus-The importance of symptoms such as fatigue

    Cross-sectional study

  25. Rheumatology (Oxford)

    Incidence and risk of arterial and venous thrombotic events in systemic lupus erythematosus patients: a population-based study

    Cohort study

  26. Arthritis Res Ther

    Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus

    Cohort study

  27. Lupus

    Mortality and prognostic factors among inpatients with systemic lupus erythematosus in China: A 20-year retrospective study

    Case-control study

  28. Arthritis Res Ther

    Activation of circulating TFH17 cells associated with activated naive and double negative 2 B cell expansion, and disease activity in systemic lupus erythematosus patients

    Cross-sectional study

  29. Lupus

    Alterations of the microbiome across body sites in systemic lupus erythematosus: A systematic review and meta-analysis

    Meta-analysis

  30. Lupus

    Predictors of first hospitalization due to disease activity and infections in systemic lupus erythematosus patients

    Cohort study

  31. Lupus Sci Med

    Topological structural characteristics in patients with systemic lupus erythematosus with and without neuropsychiatric symptoms

    Cross-sectional study

  32. Rheumatology (Oxford)

    Association of gut commensal translocation with autoantibody production in systemic lupus erythematosus

    Mechanistic study

  33. Arthritis Care Res (Hoboken)

    The Impact of Pregnancy Readiness on Lupus Activity, Maternal Mental Health, and Pregnancy Outcomes

    Cohort study

  34. Lupus

    Characteristics and outcomes of biopsy-proven lupus nephritis in the Eastern Cape province of South Africa

    Cohort study

  35. Lupus

    Optical coherence tomography angiography findings of systemic lupus erythematosus patients and the effect of neuropsychiatric involvement on it

    Cross-sectional study

  36. Lupus

    Using linked electronic medical record-pharmacy data to examine lupus medication adherence: A retrospective cohort study

    Cohort study

  37. Lupus

    Characteristic features of late-onset systemic lupus erythematosus: An observational study of data from the Lupus Registry of Nationwide Institutions

    Cohort study

  38. Clin Exp Rheumatol

    Heterogeneity of peripheral immune cell landscape in systemic lupus erythematosus patients after belimumab treatment

    Mechanistic study

  39. JAMA Netw Open

    Mycophenolate Mofetil and New-Onset Systemic Lupus Erythematosus: A Randomized Clinical Trial

    Randomized controlled trial

  40. Lupus Sci Med

    Monoclonal gammopathy in systemic lupus erythematosus is associated with distinctive clinical course, malignancy and mortality rate: a single-centre retrospective cohort study

    Cohort study

All 1,848 Briefs in ExploreShowing Briefs 1,041–1,080 of 1,848, newest first